These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19916034)

  • 1. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.
    McBride SJ; Upton A; Roberts SA
    Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):107-14. PubMed ID: 19916034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study.
    Pinholt M; Ostergaard C; Arpi M; Bruun NE; Schønheyder HC; Gradel KO; Søgaard M; Knudsen JD;
    Clin Microbiol Infect; 2014 Feb; 20(2):145-51. PubMed ID: 23647880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia in cancer patients.
    Conde-Estévez D; Grau S; Albanell J; Terradas R; Salvadó M; Knobel H
    Eur J Clin Microbiol Infect Dis; 2011 Jan; 30(1):103-8. PubMed ID: 20711795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterococcal bacteraemia: predictive and prognostic risk factors for ampicillin resistance.
    Matsumura T; Nagao M; Nakano S; Yamamoto M; Matsumura Y; Ichiyama S
    Epidemiol Infect; 2018 Dec; 146(16):2028-2035. PubMed ID: 30165917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.
    Hayakawa K; Marchaim D; Martin ET; Tiwari N; Yousuf A; Sunkara B; Pulluru H; Kotra H; Hasan A; Bheemreddy S; Sheth P; Lee DW; Kamatam S; Bathina P; Nanjireddy P; Chalana IK; Patel S; Kumar S; Vahia A; Ku K; Yee V; Swan J; Pogue JM; Lephart PR; Rybak MJ; Kaye KS
    Antimicrob Agents Chemother; 2012 May; 56(5):2452-8. PubMed ID: 22354290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan.
    Suzuki H; Hase R; Otsuka Y; Hosokawa N
    J Infect Chemother; 2017 Jun; 23(6):390-393. PubMed ID: 28385565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme (AESOP) Annual Report 2017.
    Coombs GW; Daley DA; Lee YT; Pang S
    Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective observational study on enterococcal bacteraemia and endocarditis at a regional hospital in New South Wales, Australia.
    Lwin N; Bannan A
    Infect Dis Health; 2020 Nov; 25(4):245-252. PubMed ID: 32561340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian Enterococcal Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Pearson JC; Daly DA; Le TT; Robinson JO; Gottlieb T; Howden BP; Johnson PD; Bennett CM; Stinear TP; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E320-6. PubMed ID: 25631594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis.
    Lu CL; Chuang YC; Chang HC; Chen YC; Wang JT; Chang SC
    J Antimicrob Chemother; 2012 Sep; 67(9):2243-9. PubMed ID: 22618861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing trend in enterococcal bacteraemia and vancomycin resistance in a tertiary care hospital in Croatia, 2017-2021.
    Todorić Z; Majdandžić I; Keretić Kregar T; Herljević Z; Ćorić M; Lešin J; Kuliš T; Mareković I
    Infect Dis (Lond); 2023 Jan; 55(1):9-16. PubMed ID: 36240424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of enterococcal bacteremia in Australia.
    Coombs GW; Pearson JC; Daley DA; Le T; Robinson OJ; Gottlieb T; Howden BP; Johnson PD; Bennett CM; Stinear TP; Turnidge JD;
    J Clin Microbiol; 2014 Mar; 52(3):897-905. PubMed ID: 24391201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia.
    Suppola JP; Kuikka A; Vaara M; Valtonen VV
    Scand J Infect Dis; 1998; 30(2):153-7. PubMed ID: 9730302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
    Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B
    BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study.
    Billington EO; Phang SH; Gregson DB; Pitout JD; Ross T; Church DL; Laupland KB; Parkins MD
    Int J Infect Dis; 2014 Sep; 26():76-82. PubMed ID: 24813873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
    Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
    Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing proportion of vancomycin-resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018.
    Piezzi V; Gasser M; Atkinson A; Kronenberg A; Vuichard-Gysin D; Harbarth S; Marschall J; Buetti N; ;
    Euro Surveill; 2020 Sep; 25(35):. PubMed ID: 32885778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary Care Hospital in Northern India.
    Tripathi A; Shukla SK; Singh A; Prasad KN
    Indian J Med Microbiol; 2016; 34(1):38-45. PubMed ID: 26776117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.